BOXED WARNING NSAID class risk: serious cardiovascular thrombotic events (MI, stroke) — contraindicated in CABG setting; serious GI bleeding, ulceration, and perforation, which can be fatal.
FDA dosing
Population
Start
Target
Max
Mild to moderate pain
Adults & ≥14 yr
500 mg once, then 250 mg q6h PRN
250 mg q6h PRN
Primary dysmenorrhea
Adults & ≥14 yr
500 mg once, then 250 mg q6h (from onset of bleeding)
250 mg q6h
Renal Should not be given to patients with pre-existing renal disease or significantly impaired renal function; avoid in advanced renal disease unless benefits outweigh risks.
Hepatic May require reduced doses in acute or chronic hepatic disease.
Instructions
Use the lowest effective dose for the shortest duration.
Avoid using more than one NSAID at a time.
Contraindications
History of asthma, urticaria, or other allergic-type reactions to aspirin or other NSAIDs.
In the setting of coronary artery bypass graft (CABG) surgery.
elevated liver enzymes, abnormal renal function, increased bleeding time
Pregnancy Avoid at ~30 weeks gestation and later (premature closure of fetal ductus arteriosus); limit dose/duration at 20–30 weeks (oligohydramnios/fetal renal dysfunction).
Lactation Present in human milk in low amounts; weigh benefits against potential effects on the infant.
⚠ BOXED WARNINGS
Cardiovascular thrombotic events
Gastrointestinal bleeding, ulceration and perforation